last month, Yuca Sciences Inc. SAVA agreed to pay more than $40 million to resolve SEC charges of misleading statements related to a Phase 2 trial of the company's controversial Alzheimer's drug, simufilam. The SEC also loaded Dear Yan Wangconsultant and co-developer of the drug, manipulating the results of the …
Top Wall Street analysts changed their outlook on these big names. For a complete view of all analyst rating changes, including upgrades and downgrades, see our analyst ratings page. Bernstein analyst Bokyung Suh upgraded Coupang, Inc.. CPG from underperform to outperform and announced a $30 price target. Coupang shares gained …
wedbush analyst Nick Setyan updated Dine Global Brands, Inc. OF to Outperform from Neutral, raising the forecast price to $47 from $34. The analyst identifies key catalysts for Dine Brands' multiple expansions over the next twelve months. According to Setyan, an accelerated share buyback plan worth more than $100 million …
Top Wall Street analysts changed their outlook on these big names. For a complete view of all analyst rating changes, including upgrades and downgrades, see our analyst ratings page. TD Cowen analyst Bryan Bergin upgraded Accenture plc ACN from Hold to Buy and raised the price target from $321 to …
amphenol APH It looks like an attractive option, as it has recently been upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates, one of the most powerful forces affecting stock prices. A company's changing earnings picture is at the …
Limbach LMB It could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates, one of the most powerful forces affecting stock prices. The sole determinant of a Zacks rating …
Top Wall Street analysts have changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Thinking about buying JWN stock? Here's what analysts think: Market news and data provided by Benzinga APIs © 2024 …
Top Wall Street analysts have changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Thinking about buying BAC stock? Here's what analysts think: Market news and data provided by Benzinga APIs © 2024 …
Top Wall Street analysts have changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Thinking about buying MRNA stock? Here's what analysts think: Market news and data provided by Benzinga APIs © 2024 …
Renasant Corporation RNST Shares plunged in early trading on Monday, a week after announcing a public offering of 6.25 million shares. He First Bank Shares Inc. Facebook File Management System The announcement of the deal and the $230 million common equity raising “significantly changes the future trajectory” of Renasant, according …